U.S. Markets close in 56 mins

Select Medical Corporation Announces Pricing of 6.250% Senior Notes due 2026

MECHANICSBURG, Pa., July 29, 2019 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (SEM), today announced that Select Medical Corporation ("Select") has priced its private placement of $550.0 million aggregate principal amount of its 6.250% senior notes due 2026. The offering is expected to close on August 1, 2019, subject to the satisfaction of customary closing conditions.

Select intends to use a portion of the net proceeds of the offering, together with a portion of the proceeds from a proposed $500.0 million incremental term loan, to redeem in full the $710.0 million aggregate principal amount of Select's outstanding 6.375% Senior Notes due 2021 at the applicable redemption price of 100% of the principal amount thereof, plus interest accrued to, but excluding, the date of redemption, to repay in full the outstanding borrowings under Select's revolving credit facility, including any accrued and unpaid interest thereon, and to pay related fees and expenses.

The notes and related guarantees are being offered in a private placement, solely to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), or outside the United States to persons other than "U.S. persons" in compliance with Regulation S under the Securities Act. The notes and related guarantees have not been registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.

This notice does not constitute an offer to sell the notes, nor a solicitation for an offer to purchase the notes, in any jurisdiction in which such offer or solicitation would be unlawful. Any offer of the notes will be made only by means of a private offering memorandum. This press release is being issued pursuant to and in accordance with Rule 135c under the Securities Act.

Investor inquiries: 
Joel T. Veit 
Senior Vice President and Treasurer 


View original content:http://www.prnewswire.com/news-releases/select-medical-corporation-announces-pricing-of-6-250-senior-notes-due-2026--300892665.html